Jan 21, 2022 / 03:30AM GMT
Aishwarya Sitharam - Biocon Limited - Head of IR
Good morning, everyone. I'm Aishwarya Sitharam from the Biocon Investor Relations team, and I would like to welcome you to Biocon's earnings call for Q3 FY '22. (Operator Instructions) I'd also like to bring to your attention that this conference is being recorded.
To discuss the company's business performance and outlook, we have with us today the Biocon leadership team comprising of Dr. Kiran Mazumdar-Shaw, our Executive Chairperson, and other senior management colleagues.
I'd like to take this opportunity to also remind everyone about safe harbor. Today's discussion may be forward-looking in nature based on management's current beliefs and expectations. It must be viewed in concurrence with the risks that our business faces that could cause our future results, performance or achievements to differ significantly from what is expressed or implied by such forward-looking statements. At the end of this call, if you need any further information or clarifications, please do get in touch with Nikunj or me.
I would now like to turn
Q3 2022 Biocon Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot